Dr. Sanjay Logani, MD

Dr. Logani practices at Advanced Retina Associates Medical Group, Inc in Reseda, California.

Dr. Logani's NPI, 1124131958, was assigned on August 16, 2006. Dr. Logani graduated from Feinberg School of Medicine in 1990. Dr. Logani holds California license G73456.

Dr. Logani's primary practice is Advanced Retina Associates Medical Group, Inc, at 17750 W Sherman Way, Reseda, CA 91335 in Los Angeles County. The practice phone is (818) 886-6700.

Dr. Logani's primary practice is Advanced Retina Associates Medical Group, Inc in Reseda, California. Dmand AI also links Dr. Logani to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Logani practices. Vendor and product names are available with a free account.

Retina specialist is Dr. Logani's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Logani is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Logani's licenses on file in 2 states: California and Illinois.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma and hypertensive retinopathy among the conditions Dr. Logani treats.

CMS data shows 27,125 Medicare services from Dr. Logani across 29 procedure codes in 2024, for 804 Medicare patients. Medicare paid $1,078,492 for them. Every service was in an office.

CMS counts 804 Medicare patients who saw Dr. Logani in 2024. The largest group is 65 to 74, with 380 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 88% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Logani's median patient age at 62, with 60% women.

In 2024, Dr. Logani wrote 2,507 Medicare Part D claims for 634 patients. 52% of them were for generic drugs. CMS names the drug for 2,412 of them, across 21 drugs with 11 or more claims each, at $721,286 in total drug cost. In 2023, CMS named 1,587 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Logani for performance year 2024, reported as part of a group. Dr. Logani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 64 procedures of cataract surgery by Dr. Logani, more than 67% of the clinicians it reports for that procedure.

CMS Open Payments shows 303 general payments to Dr. Logani from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Carl Zeiss Meditec, Inc. paid the most, $2,000.

Dmand AI lists 2 awards for Dr. Logani, most recently Heed Knapp Award in 1995.

Dr. Logani graduated from Feinberg School of Medicine in 1990. Dr. Logani is a member of AAO, ACS and ASRS.

Dr. Logani is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.